Ceritinib (Noxalk) 150mg*90's | Natco India Generic | GLT

Generic Information: Noxalk (India)

Noxalk is an Indian generic of ceritinib produced by Natco Pharma Limited, a well-established Indian manufacturer known for affordable oncology medicines. Each capsule contains 150 mg of ceritinib, with 90 capsules per pack. As a generic of the second-generation ALK inhibitor Zykadia, Noxalk delivers the same active ingredient and therapeutic effect at a lower cost, making long-term ALK-targeted therapy more affordable.

What Is Noxalk Used For?

Noxalk is used for ALK-positive metastatic non-small cell lung cancer, the same indication as originator ceritinib. It is prescribed for patients whose cancer has progressed on crizotinib and, where locally approved, as first-line therapy for newly diagnosed ALK-positive disease. It offers a cost-effective oral option for patients who need to stay on treatment for many months.

How Does Ceritinib (Noxalk) Work?

Ceritinib inhibits anaplastic lymphoma kinase, the abnormal protein produced when ALK is fused to another gene in lung cancer. By blocking ALK — along with related kinases — the drug suppresses the growth signals that cancer cells rely on. Its activity against crizotinib-resistant ALK mutations makes it especially useful after first-generation therapy has failed.

Indications

The approved indication is ALK-positive metastatic NSCLC, confirmed by molecular testing. Noxalk is used after crizotinib progression and as an initial targeted therapy for ALK-positive disease. Treatment requires prescription and supervision by an oncology specialist.

Dosage

The standard dose is 450 mg (three capsules) once daily with food, providing the same efficacy as the older 750 mg fasting schedule with better tolerance. A 90-capsule pack lasts 30 days at the 450 mg daily dose. The oncologist may interrupt or reduce the dose to manage side effects or abnormal liver tests.

Side Effects

The most frequent side effects are gastrointestinal — diarrhoea, nausea, vomiting and abdominal pain — plus fatigue and loss of appetite. Important effects include elevated liver enzymes, high blood sugar, QT-interval prolongation and, rarely, pneumonitis. Regular monitoring of liver function, blood glucose and heart rhythm is required, and persistent symptoms should be reported to the treating physician.

Storage

Store Noxalk capsules at room temperature, protected from moisture and light, in the original container and out of reach of children. Do not use past the expiry date.

Why Choose Noxalk Through GLT?

Noxalk provides access to ceritinib at a fraction of the originator's price. Sourcing this Indian generic through GLT means patients and institutions can obtain genuine Natco product with verified documentation, at a cost far below Western brand prices — a practical choice for long-term ALK-targeted treatment where affordability matters.

How to Order

To order Noxalk (ceritinib) from GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. We confirm availability and pricing, and ship from a Hong Kong-licensed facility to your country.

FAQ

Is Noxalk as effective as Zykadia? As a generic, Noxalk contains the same active ingredient ceritinib at the same dose, so its therapeutic effect is equivalent to the originator.

Who makes Noxalk? Noxalk is manufactured by Natco Pharma Limited, a well-known Indian pharmaceutical company with a strong oncology portfolio.

How long does a 90-capsule pack last? At 450 mg once daily (three capsules), a 90-capsule pack covers 30 days of treatment.